Risk of Non-Hodgkin Lymphoma Following Treatment of Inflammatory Conditions with Tumor Necrosis Factor-Alpha Inhibitors

被引：0
|
作者：
Calip, Gregory S. [1 ,2 ,3 ]
Lee, Wan-Ju [1 ,2 ]
Lee, Todd A. [1 ,2 ]
Schumock, Glen T. [1 ,2 ]
Chiu, Brian C-H. [4 ]
机构：
[1] Univ Illinois, Ctr Pharmacoepidemiol & Pharmacoecon Res, Chicago, IL USA
[2] Univ Illinois, Dept Pharm Syst Outcomes & Policy, Chicago, IL USA
[3] Univ Illinois, Ctr Canc, Populat Hlth Behav & Outcomes Program, Chicago, IL USA
[4] Univ Chicago, Dept Publ Hlth Sci, Chicago, IL 60637 USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Lessons learned in the use of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis
    Ted R. Mikuls
    Arthur L. Weaver
    [J]. Current Rheumatology Reports, 2003, 5 (4) : 270 - 277
  • [32] Appearance of ANCA - associated vasculitis under Tumor necrosis factor-alpha inhibitors treatment
    Reitblat, Tatiana
    Reitblat, Olga
    [J]. AMERICAN JOURNAL OF CASE REPORTS, 2013, 14 : 80 - 82
  • [33] Characterization of the treatment of rheumatoid arthritis for patients prescribed tumor necrosis factor-alpha inhibitors
    Stockl, K
    Jarrar, M
    Tandon, N
    [J]. VALUE IN HEALTH, 2004, 7 (03) : 245 - 245
  • [34] Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome
    Warzocha, K
    Ribeiro, P
    Bienvenu, J
    Roy, P
    Charlot, C
    Rigal, D
    Coiffier, B
    Salles, G
    [J]. BLOOD, 1998, 91 (10) : 3574 - 3581
  • [35] Association analysis of genetic variants in the ghrelin and tumor necrosis factor α genes and the risk for non-Hodgkin's lymphoma in Kuwaitis
    Alrashid, Maryam H.
    Al-Serri, Ahmad
    Alshemmari, Salem H.
    Geo, Jeethu Anu
    Al-Bustan, Suzanne A.
    [J]. CANCER BIOMARKERS, 2021, 32 (01) : 11 - 18
  • [36] HBV infection as a risk factor for non-Hodgkin lymphoma
    Jeong, Sook-Hyang
    [J]. LANCET ONCOLOGY, 2010, 11 (09): : 806 - 806
  • [37] Altered immunity as a risk factor for non-Hodgkin lymphoma
    Grulich, Andrew E.
    Vajdic, Claire M.
    Cozen, Wendy
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (03) : 405 - 408
  • [38] Blood transfusion as a risk factor for non-Hodgkin lymphoma
    Brandt, L
    Brandt, J
    Olsson, H
    Anderson, H
    Moller, T
    [J]. BRITISH JOURNAL OF CANCER, 1996, 73 (09) : 1148 - 1151
  • [39] Correction to: Treatment Persistence in Patients Cycling on Subcutaneous Tumor Necrosis Factor-Alpha Inhibitors in Inflammatory Arthritis: A Retrospective Study
    Johan Dalén
    Amy Puenpatom
    Karin Luttropp
    Axel Svedbom
    Christopher M. Black
    [J]. Advances in Therapy, 2022, 39 : 256 - 256
  • [40] Risk of Primary Gastrointestinal Lymphoma in Patients With Inflammatory Conditions Exposed to Tumor Necrosis Factor Alpha Inhibitors and Immunomodulators: A Case-Control Study
    Braga-Neto, Manuel B.
    Nasser, Jason
    Wang, Xiao Xing
    Harmsen, William Scott
    Raffals, Laura E.
    Camilleri, Michael
    Chedid, Victor
    [J]. CROHNS & COLITIS 360, 2024, 6 (01)
12345